Fig. 1From: Contribution of ESC DAPT guideline-endorsed high thrombotic risk features to long-term clinical outcomes among patients with and without high bleeding risk after PCIKaplan-Meier event rates for the ischemic and bleeding outcomes according to ESC guideline-endorsed HTR status. Cumulative incidence of major adverse cardiac events (MACE) (a), device-oriented composite endpoint (DOCE) (b), myocardial infarction (c), clinically relevant bleeding (d). Red lines indicate patients with HTR. Blue lines indicate patients with non-HTR. HTR = high thrombotic risk; CI = confidence interval; HR = hazard ratioBack to article page